All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration (Q47918470)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 November 2011

Language	Label	Description	Also known as
English	All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration	scientific article published on 28 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

1 reference

based on heuristic

inferred from title

Paz Sobrino-Vegas

object named as

Paz Sobrino-Vegas

17

0 references

Antonella Castagna

object named as

Antonella Castagna

19

0 references

object named as

Caroline Sabin

5

0 references

object named as

Matthias Egger

27

0 references

6

object named as

Amanda Mocroft

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Geneviève Chêne

29

object named as

Geneviève Chêne

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Antonella d'Arminio Monforte

21

object named as

Antonella d'Arminio Monforte

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Andrea Antinori

20

object named as

Andrea Antinori

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Alexandra Calmy

25

object named as

Alexandra Calmy

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

François Dabis

13

object named as

François Dabis

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

10

object named as

Niels Obel

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

8

object named as

Ard van Sighem

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Cristina Mussini

23

object named as

Cristina Mussini

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

26

object named as

Ramón Teira

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

12

object named as

Jade Ghosn

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Stéphane De Wit

4

object named as

Stéphane De Wit

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Catherine Leport

15

object named as

Catherine Leport

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

9

object named as

Ole Kirk

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

author name string

Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Charlotte Lewden

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Vincent Bouteloup

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Jan Christian Wasmuth

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

George Panos

11

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Murielle Mary-Krause

14

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Santiago Perez-Hoyos

16

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Christoph Stephan

18

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Carlo Torti

22

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Virginia Isern

24

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Jesper Grarup

28

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

publication date

28 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

International Journal of Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

41

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

433-445

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Changes in the risk of death after HIV seroconversion compared with mortality in the general population

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Survival of persons with and without HIV infection in Denmark, 1995-2005.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Response to combination antiretroviral therapy: variation by age.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Trends in mortality and causes of death among women with HIV in the United States: a 10-year study

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Poverty, hunger, education, and residential status impact survival in HIV.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Aging and HIV infection: a comparison between older HIV-infected persons and the general population

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR164

21 January 2018

Identifiers

10.1093/IJE/DYR164

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/22493325

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47918470&oldid=2175722614"